Oxidation and detoxification of trivalent arsenic species

Toxicology and Applied Pharmacology

Volumn 193, Issue 1, 2003, Pages 1-8

  Aposhian, H Vasken ^a,b   Zakharyan, Robert A ^a   Avram, Mihaela D ^a   Kopplin, Michael J ^b   Wollenberg, Michael L ^a  

^a University of Arizona   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; ARSENIC ACID; ARSENIC DERIVATIVE; ARSENIC TRIOXIDE; CATALASE; HYDROGEN PEROXIDE; HYDROXYL RADICAL; MANNITOL; MELATONIN; METHANEARSONIC ACID; ORGANOARSENIC DERIVATIVE; POTASSIUM IODIDE; XANTHINE OXIDASE;

ARTICLE; CHEMICAL REACTION; DETOXIFICATION; METHYLATION; OXIDATION;

LETHRINIDAE; MAMMALIA;

EID: 0242594013     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-008X(03)00324-7     Document Type: Article

References (62)

1. Ahmad K., Kitchin K.T., Cullen W.R. Arsenic species that cause release of iron from ferritin and generation of activated oxygen. Arch. Biochem. Biophys. 382:2000;195-202.
2. Aposhian H.V. Enzymatic methylation of arsenic species and other new approaches to arsenic toxicity. Annu. Rev. Pharmacol. Toxicol. 37:1997;397-419.
3. Aposhian H.V., Gurzau E.S., Le X.C., Gurzau A., Healy S.M., Lu X., Ma M., Yip L., Zakharyan R.A., Maiorino R.M., Dart R.C., Tircus M.G., Gonzalez-Ramirez D., Morgan D.L., Avram D., Aposhian M.M. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem. Res. Toxicol. 13:2000;693-697.
4. III), excreted in human urine. Toxicol. Appl. Pharmacol. 165:2000;74-83.
5. Barchowsky A., Klei L.R., Dudek E.J., Swartz H.M., James P.E. Stimulation of reactive oxygen, but not reactive nitrogen species, in vascular endothelial cells exposed to low levels of arsenite. Free Radical Biol. Med. 27:1999;1405-1412.
6. Bates M.N., Smith A.H., Hopenhayn-Rich C. Arsenic ingestion and internal cancers a review . Am. J. Epidemiol. 135:1992;462-476.
7. Boveris Alberto. Biochemistry of free radicals from electrons to tissues . Medicina (Buenos Aires). 58:1998;350-356.
8. Chakraborti D., Mohammed M.R., Paul K., Chowdhury U.K., Sengupta M.K., Lodh D., Chanda C.R., Saha K.C., Mukherjee S.C. Arsenic calamity in the Indian subcontinent what lessons have been learned? Talanta. 58:2002;3-22.
9. Chance B., Sles H., Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59:1979;527-605.
10. Coughlan M.P., Rajagopalan K.V., Handler P. The role of molybdenum in xanthine oxidase and related enzymes. J. Biol. Chem. 244:1969;2658-2663.
11. Del Razo L.M., Styblo M., Cullen W.R., Thomas D.J. Determination of trivalent methylated arsenicals in biological matrices. Toxicol. Appl. Pharmacol. 174:2001;282-293.
12. Enroth C., Eger B.T., Okamoto K., Nishino T., Nishino T., Pai E.F. Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase structure-based mechanism of conversion . Proc. Natl. Acad. Sci. USA. 97:2000;10723-10728.
13. Gong Z., Lu X., Cullen W.R., Le X.C. J. Anal. At. Spectrom. 16:2001;1409-1413.
14. Gregus Z., Gyurasics A., Csanaky I. Biliary and urinary excretion of inorganic arsenic monomethylarsonous acid as a major biliary metabolite in rats . Toxicol. Sci. 56:2000;18-25.
15. Gregus Z., Németi B. Purine nucleoside phosphorylase as a cytosolic arsenate reductase. Toxicol. Sci. 70:2002;13-19.
16. Healy S.M., Zakharyan R.A., Aposhian H.V. Enzymatic methylation of arsenic compounds. IV. In vitro and in vivo deficiency of the methylation of arsenite and monomethylarsonic acid in the guinea pig. Mutat. Res. 386:1997;229-239.
17. Henderson L.M., Chappel J.B. NADPH oxidase of neutrophils. Biochim. Biophys. Acta. 1273:1996;87-107.
18. Hille R. The mononuclear molybdenum enzymes. Chem. Rev. 96:1996;2757-2816.
19. Hille R., Nishino T. Xanthine oxidase and xanthine dehydrogenase. FASEB J. 9:1995;995-1003.
20. Hille R., Stewart R.C., Fee J.A., Massey V. The interaction of arsenite with xanthine oxidase. J. Biol. Chem. 258:1983;4849-4856.
21. Hoidal J.R. Reactive oxygen species and cell signaling. Am. J. Respir. Cell Mol. Biol. 25:2001;661-663.
22. Hughes M.F. Arsenic toxicity and potential mechanisms of action. Toxicol. Lett. 133:2002;1-16.
23. IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Humans. Some Metals and Metallic Compounds. 1980;World Health Organization, Lyon, France. Vol. 23.
24. IARC (International Agency for Research on Cancer), 1987. IARC Monograph on the Evaluation of Carcinogenic Risks to Humans: Overall Evaluation of Carcinogenicity: An Update of IARC Monographs 1 to 42, International Agency for Research on Cancer, Lyon, France, Suppl. 7, p. 100.
25. Ichida K., Amaya Y., Noda K., Minoshima S., Hosoya T., Sakai O., Shimizu N., Nishino T. Cloning of the cDNA encoding human xanthine dehydrogenase (oxidase) structural analysis of the protein and chromosomal location of the gene . Gene. 133:1993;279-284.
26. Kala S.V., Neely M.W., Kala G., Prater C.I., Atwood D.W., Rice J.S., Lieberman M.W. The MRP2/cMOAT transporter and arsenic-glutathione complex formation are required for biliary excretion of arsenic. J. Biol. Chem. 275:2000;33404-33408.
27. Lacy, F., Kailasam, M.T., O'Connor, D.T., Schmid-Schönbein, Parmer, R.J., 2000. Plasma hydrogen peroxide production in human essential hypertension. Hypertension 36, 878-884.
28. Le X.C., Lu X., Ma M., Cullen W.R., Aposhian H.V., Zheng B. Speciation of key arsenic metabolic intermediates in human urine. Ana. Chem. 72:2000;5172-5177.
29. Le X.C., Ma M., Lu X., Cullen W.R., Aposhian H.V., Zheng B. Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ. Health Perspect. 108:2000;1015-1018.
30. Liu S.X., Athar M., Lippai I., Waldren C., Hei Tom K. Induction of oxyradicals by arsenic implication for mechanism of genotoxicity . Proc. Natl. Acad. Sci. USA. 98:2001;1643-1648.
31. Maia L., Mira L. Xanthine oxidase and aldehyde oxidase a simple procedure for the simultaneous purification from rat liver . Arch. Biochem. Biophys. 400:2002;48-53.
32. Mandal B.K., Ogra Y., Suzuki K.T. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India. Chem. Res. Toxicol. 14:2001;371-378.
33. Mihalik S.J., McGuinness M., Watkins P.A. Purification and characterization of peroxisomal L-pipecolic acid oxidase from monkey liver. J. Biol. Chem. 266:1991;4822-4830.
34. Mihalik S.J., Rhead W.J. L-pipecolic acid oxidation in the rabbit and cynomolgus monkey evidence for differing organellar locations and cofactor requirements in each species . J. Biol. Chem. 264:1989;2509-2517.
35. Németi B., Gregus Z. Reduction of arsenate to arsenite in hepatic cytosol. Toxicol. Sci. 70:2002;4-12.
36. Nordstrom D.K. Worldwide occurrences of arsenic in ground water. Science. 296:2002;2143-2145.
37. Parks D.A., Granger D.N. Xanthine oxidase biochemistry distribution and physiology . Acta Physiol. Scand. 548:1986;87-99.
38. Peters J.M., Sanadi D.R. Effect of arsenite and cadmium ions on xanthine oxidase. Arch. Biochem. Biophys. 93:1961;312-313.
39. III) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 163:2000;203-207.
40. 50 in hamsters and in vitro inhibition of pyruvate dehydrogenase . Chem. Res. Toxicol. 14:2001;651-656.
41. 2. Mar. Chem. 70:2000;223-234.
42. Nesnow S., Roop B.C., Lambert G., Kadiiska M., Mason R.P., Cullen W.R., Mass M.J. DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem. Res. Toxicol. 15:2002;1627-1634.
43. Radabaugh T.R., Sampayo-Reyes A., Zakharyan R.A., Aposhian H.V. Arsenate reductase II. Purine nucleoside phosphorylase in the presence of dihydrolipoic acid is a route for reduction of arsenate to arsenite in mammalian systems. Chem. Res. Toxicol. 15:2002;692-698.
44. 74As-labeled arsenate and arsenite for use in biological experiments. Anal. Biochem. 78:1977;557-560.
45. Rossman T.G., Uddin A.N., Burns F.J., Bosland M.C. Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin an animal model for arsenic carcinogenesis . Toxicol. Appl. Pharmacol. 176:2001;64-71.
46. Samikkanu, T., Chen, C.-H., C. Yih, L.-H., Wang, A.S.S., Lin, S.-Y., Chen, T.-C., Jan, K.-Y., 2002. Reactive oxygen species are involved in arsenic trioxide inhibition of pyruvate dehydrogenase activity. Chem. Res. Toxicol. 16, 409-414.
47. Sampayo-Reyes A., Zakharyan R.A., Healy S.M., Aposhian H.V. Monomethylarsonic acid reductase and monomethylarsonous acid in hamster tissue. Chem. Res. Toxicol. 13:2000;1181-1186.
48. Scott N., Hatlelid K.M., MacKenzie N.E., Carter D.E. Reactions of arsenic (III) and arsenic (V) with glutathione. Chem Res. Toxicol. 6:1993;102-106.
49. Stewart R.C., Hille R., Massey V. Characterization of arsenite-complexed xanthine oxidase at room temperature. J. Biol. Chem. 259:1984;14426-14436.
50. Styblo M., Del Razo L.M., Vega L., Germolec D.R., LeCluyse E.L., Hamilton G.A., Reed W., Wang C., Cullen W.R., Thomas D.J. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74:2000;289-299.
51. Tamura H., Iida T., Watanabe T., Suga T. Long-term effects of peroxisome proliferators on the balance between hydrogen peroxide-generating and scavenging capacities in the liver of Fisher-344 rats. Toxicology. 63:1990;199-213.
52. 2-generating NADH oxidase in human lung fibroblasts by transforming growth factor β1. J. Biol. Chem. 270:1995;30334-30338.
53. Thomas D.J., Styblo M., Lin S. The cellular metabolism and systemic toxicity of arsenic. Toxicol. Appl. Pharmacol. 176:2001;127-144.
54. Vahter M. Species differences in the metabolism of arsenic compounds. Appl. Organomet. Chem. 8:1994;175-182.
55. Vahter M., Couch R., Nermell B., Nilsson R. Lack of methylation of inorganic arsenic in the chimpanzee. Toxicol. Appl. Pharmacol. 133:1995;262-268.
56. Vahter M., Marafante E. In vivo methylation and detoxication of arsenic. Craig P.J., Glocking F. The Biological Alkylation of Heavy Elements. 66:1988;105-119 Royal Society of Chemistry, Special Publication, London.
57. 74As-arsenite. Arch. Toxicol. 51:1982;65-77.
58. Wildfang E., Radabaugh T.R., Aposhian H.V. Enzymatic methylation of arsenic compounds. IX. Liver arsenite methyltransferase and arsenate reductase activities in primates. Toxicology. 168:2001;213-221.
59. Zakharyan R.A., Sampayo-Reyes A., Healy S.M., Tsaprailis G., Board P.G., Liebler D.C., Aposhian H.V. Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily. Chem. Res. Toxicol. 14:2001;1051-1057.
60. Zakharyan R.A., Wildfang E., Aposhian H.V. Enzymatic methylation of arsenic compounds. III. The marmoset and tamarin, but not the rhesus, monkey are deficient in methyltransferase that methylate inorganic arsenic. Toxicol. Appl. Pharmacol. 140:1996;77-84.
61. Zakharyan R.A., Wu Y., Bogdan G.M., Aposhian H.V. Enzymatic methylation of arsenic compounds assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver . Chem. Res. Toxicol. 8:1995;1029-1038.
62. Zhao C.Q., Young M.R., Diwan B.A., Coogan T.P., Waalkes M.P. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc. Natl. Acad. Sci. USA. 94:1997;10907-10912.